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A comparative study was undertaken to characterize the very early events that distinguish attenuated and pathogenic
simian immunodeficiency virus (SIV) infections. Three rhesus macaques were inoculated with the attenuated SIVmac 251
Dnef virus, and three others with a virus of intermediate phenotype, SIVmac 239 nef stop. They were compared to four
macaques inoculated with the pathogenic SIVmac 251 isolate. Lymph nodes (LN) taken between 7 days and 2 months
postinoculation were analyzed for SIV expression by in situ hybridization. During acute infection, SIV 251 Dnef infected 1
to 1.5 log10 fewer cells in LN tissue than the pathogenic SIV 251 isolate. The reduction was more marked in the blood, as
SIV 251 Dnef infected 2 to 3 log10 fewer PBMC than the isolate and did not yield detectable antigenemia. Morphometric
measurements showed that the development of germinal centers (GC) was more rapid in the Dnef infection, which led to
a more efficient trapping of viral particles, and could account for antigenemia clearance. The SIV 239 nef stop clone reverted
to a nef/ genotype at Week 2, but induced a lower viral burden than a directly pathogenic virus. The kinetics of GC
development was rapid, indicating that SIV 239 nef stop induced an immune response similar to that seen in attenuated
infection. This study provides evidence that attenuated SIV elicits a more rapid immune response than pathogenic SIV and
suggests that an early immunosuppressive episode may facilitate the dissemination of pathogenic SIV. q 1995 Academic
Press, Inc.
INTRODUCTION (Pantaleo et al., 1994). Taken together, these studies indi-
cate that pathologic events occur early and stress the
Primary infection with HIV is characterized by a tran-
need to investigate how the virus spreads and interferes
sient but intense stage of viral replication and dissemina-
with the immune response during primary infection.tion (Clark et al., 1991; Daar et al., 1991; Piatak et al.,
Animal models of AIDS allow an in-depth analysis of
1993a,b; Wall et al., 1987). Clinical, virological, and immu-
the primary stage of infection, a task which is difficult in
nological studies now provide a body of evidence that
humans. SIVmac infection is the model of choice, as
the course of primary HIV infection conditions the pro-
SIVmac is closely related to HIV in its genetic structure
gression to AIDS. Individuals who manifest prolonged
(Chakrabarti et al., 1987; Daniel et al., 1985) and causes
symptoms such as fever and skin rash during primary a disease in macaques remarkably similar to AIDS in
HIV infection tend to have a more rapid disease course man (Desrosiers, 1990; Letvin and King, 1990). Lymphoid
(Clark and Shaw, 1993; Niu et al., 1993; Sinicco et al., organs, which constitute the major reservoir and prefer-
1993; Tindall and Cooper, 1991). The presence of detect- ential target of HIV (Embretson et al., 1993; Gerdes and
able p24 antigenemia prior to seroconversion is associ- Flad, 1992; Pantaleo et al., 1993), are similarly affected
ated with rapid progression (Keet et al., 1993). Immuno- by SIV (Chalifoux et al., 1987; Ringler et al., 1989; Rosen-
logical markers, such as low titers of anti-p24 antibodies berg et al., 1992; Wyand et al., 1989). Studies of primary
and elevated neopterin plasmatic levels, are early pre- SIV infection in rhesus macaques have demonstrated
dictors of clinical progression (Gaines et al., 1990; Keet that intense virus replication occurs in the thymus, lymph
et al., 1993; Sheppard et al., 1991). Anecdotal evidence nodes (LN), and spleen (Baskin et al., 1991; Chakrabarti
suggests that a delayed cellular cytotoxic response may et al., 1994b; Lackner et al., 1994) and that the develop-
be associated with a bad prognosis (Koup et al., 1994) ment of the antiviral immune response in LN parallels
and that a more restricted Vb gene usage is observed the containment of virus replication (Reimann et al.,
early in CTLs of patients that progress rapidly to AIDS 1994). The immunological impairments seen in symptom-
atic primary HIV infection, such as abnormal immune
activation and delayed antibody response, have been1 To whom correspondence and reprint requests should be ad-
dressed. E-mail: chakra@pasteur.fr. reported in SIV-infected macaques (Popov et al., 1992;
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Reimann et al., 1991; Zhang et al., 1988). Thus, SIV infec- clone has a spontaneous punctual mutation in nef at
nucleotide 9353 (Regier and Desrosiers, 1990). In bothtion appears a valid model to study the early immune
dysregulation that precedes progression to AIDS. groups, the animals were intravenously inoculated with
a high dose of viral supernatant corresponding to 100,000We have previously shown that rhesus macaques that
fail to contain virus replication, as indicated by a persis- cpm in a reverse transcriptase assay. The reference
group consisted of four rhesus monkeys that were intra-tently high viral burden in LN following primary infection,
progress more rapidly toward disease (Chakrabarti et al., venously inoculated with 300,000 cpm of the pathogenic
SIVmac 251 isolate, and for which the viral burden in LN1994a). In the present study, we compared the course of
pathogenic SIV infection with that caused by SIV molecu- and blood has been previously reported (Chakrabarti et
al., 1994a). A comparison could be made between thelar clones of attenuated virulence. Our objective was to
characterize the very early events that distinguish be- three groups as we and others have shown that, in the
high range, variations in the inoculum dose have no ef-tween pathogenic and attenuated SIV infections, in order
to identify the immunopathogenic mechanisms at work fect on the course of infection (Chakrabarti et al., 1994a;
Cranage et al., 1990; Lewis et al., 1994).in the lymphoid organs. For attenuated viruses, we used
SIVmac infectious clones with mutations in the nef gene,
Lymph node and PBMC collectionbecause nef expression is known to be essential to SIV-
induced pathogenesis in adult macaques (Kestler et al., For each animal, four axillary or inguinal LN were col-
1991). Rhesus macaques inoculated with attenuated SIV lected during the early stages of infection, at Days 7, 15,
were compared to the previously studied animals, which 30, and 63 postinoculation (p.i.). LN were taken surgically
had been inoculated with the pathogenic SIVmac 251 and frozen in isopentane cooled in liquid nitrogen. After
isolate. The study demonstrates that the viral burden is embedding in O.C.T. compound (Tissue-tek, Miles), LN
reduced in attenuated infection, but proportionally more were cryostat sectioned at 4-mm intervals and the sec-
in the blood than in LN. Germinal centers (GC) develop tions were stored at 0207 until use.
more rapidly in LN infected with attenuated SIV, allowing Heparinized blood was collected from the macaques,
the efficient trapping of circulating viral particles. These diluted two times in RPMI 1640, and separated on a J-
results provide evidence of a more rapid development of prep (J. Bio) density gradient (1077 g/ml). PBMC were
the immune response in attenuated SIV infection and washed two times in RPMI 1640 and resuspended at
suggest that an early immunosuppression occurs in 107 cells/ml in RPMI 1640 supplemented with 10% fetal
pathogenic SIV infection. bovine serum. A fraction of PBMC was spotted onto
slides coated with 3-aminopropyltriethoxysilane (Sigma),
MATERIALS AND METHODS at a density of 2 1 105 cells per spot. The slides were
air-dried for a minimum of 2 hr, fixed 10 min in acetone,Animals and viruses
and kept frozen before processing by in situ hybridiza-
Six adult Rhesus monkeys (Macaca mulatta) were in- tion.
fected with SIVs derived from infectious molecular
clones. Prior to inoculation, the monkeys were demon- Serologic assays
strated to be seronegative for STLV-1, SRV-1 (type D
Antigenemia was detected by measurement of SIV p27retrovirus), herpes B virus, and SIVmac. All procedures
gag antigen in monkey sera, using a SIVmac antigenwith animals were performed under anesthesia with ket-
capture ELISA test (Coulter). Antibody response to SIVamine (Imalge`ne, Me´rieux). Three animals were inocu-
was monitored with an HIV-2 ELISA test (Elavia-II, Sanofi-lated with the attenuated SIVmac 251 Dnef virus pro-
Pasteur). The coated antigens were derived from HIV-2-vided by M. P. Kieny (Transge`ne, Strasbourg). The SIV
infected cells and cross-reacted with anti-SIV-specific251 Dnef clone was derived from the BK28 clone (Korn-
antibodies. Serum samples were tested at serial 10-foldfeld et al., 1987) by deletion of nucleotides 9226 to 9400
dilutions from 1:10 to 1:100,000.in the nef gene, mutation of the nef initiation codon ATG
to ACG at 9059, and mutation of the env in-frame stop
Determination of T4 and T8 lymphocyte subsets
codon TAG to CAG at 8785. The parental clone BK28
is partially attenuated, as it induces AIDS after a long Lymphocyte subsets were monitored by flow cytome-
try, after labeling with anti-CD4 (OKT4, Ortho-mune) andincubation period and only in a fraction of the inoculated
macaques (Israel et al., 1994; Rivie`re and Aubertin, un- anti-CD8 (Leu2a, Becton– Dickinson) monoclonal anti-
bodies conjugated to phycoerythrine and fluoresceine,published observations). Nef mutations were introduced
in the BK28 clone to ensure attenuation. respectively. EDTA-treated blood was incubated for 15
min with monoclonal antibodies added at a 1/20 dilution.The other three animals were inoculated with the SIV-
mac 239 nef stop virus provided by R. Desrosiers Red cells were lysed with the Lyse & Fix reagents (Immu-
notech). The samples were washed three times in phos-(NERPRC, Harvard Medical School). The SIV 239 nef stop
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phate-buffered saline and analyzed on a Facscan flow minimize RNA degradation during storage. Sections were
fixed in 4% paraformaldehyde and acetylated in aceticcytometer (Becton– Dickinson).
anhydride/triethanolamine (pH 8) to minimize back-
PCR and nucleotide sequencing ground. Sections were denatured in 70% formamide at
707 for 2 min to enhance the accessibility of nucleicLN DNA was amplified by nested PCR with SIV 239-
acids. The hybridization mix contained the 35S riboprobespecific primers surrounding the in-frame nef stop codon
at 50,000 dpm/ml, 50% formamide, 10% w/v dextran sul-at 9353. PCR conditions were as previously described
fate, 0.3 M NaCl, 20 mM Tris (pH 7.5), 5 mM EDTA, 10(Chakrabarti et al., 1994b). The first set of primers, SacI
mM NaH2PO4, 11 Denhardt’s, 0.5 mg/ml yeast tRNA, and(5*-GGG CTT GAG CTC ACT CTC TTG TGA G-3* ) and A2
100 mM dithiothreitol (DTT). The mix was heated at 807(5*-TGG CTG GCT ATG GAA ATT AGT CC-3* ), amplified a
for 2 min and applied to slides. Coverslips were mountedfragment of 395 base pairs (bp). Two microliters of the
and sealed with rubber cement, and hybridization wasreaction product was further amplified with primers S1
carried out at 457 overnight in a humid chamber. Slides(5*-GAA TAC TCC ATG GAG AAA CCC AG-3* ) and Nla3
were rinsed successively in 21 SSC/10 mM DTT for 1(5*-AAT GAG ACA TGT CTA TTG CCA ATT TG-3* ). The
hr at room temperature (r.t.), in 50% formamide 21 SSC/resulting 166-bp product was cloned in a Bluescript vec-
10 mM DTT for 30 min at 607, in 21 SSC for 30 min attor (Stratagene), and recombinant clones were se-
r.t., in 0.11 SSC for 1 hr at r.t., and then dehydrated inquenced in both orientations by the dideoxy-chain termi-
ethanol with 0.3 M ammonium acetate. Slides werenation method of Sanger et al. (1977).
coated with NTB2 nuclear track emulsion (Kodak) diluted
1:1 with 0.6 M ammonium acetate and autoradiographedPreparation of 35S-labeled RNA probes
for 20 days at 47. The long exposure time ensured that
RNA probes were derived from the transcription vector weak hybridization signals such as those present in ger-
Bluescript, into which a fragment of the SIVmac 142 plas- minal centers were detected. After exposure, slides were
mid clone spanning the end of env and the beginning of treated with Kodak D-19 developer, fixed, and stained
nef (nucleotides 8234 to 8721) was inserted (Chakrabarti with hematoxylin – eosin. Controls included hybridization
et al., 1987). This SIV-specific riboprobe was chosen be- of SIV-infected and uninfected cultured lymphocytes, hy-
cause all types of SIV RNAs, genomic as well as singly bridization of lymph node tissue from uninfected mon-
or doubly spliced, hybridize to this region of the genome. keys, and hybridization with a control HTLV-1 RNA probe
The probe did not overlap with the deletion in SIV 251 unrelated to SIV.
Dnef and had a sequence highly homologous to that of
SIVmac 251 and of SIVmac 239 (Kornfeld et al., 1987;
Image analysisRegier and Desrosiers, 1990), so that the hybridization
efficiency was equivalent for the three viruses used. The The diffuse hybridization in GC was quantified using
antisense riboprobe was generated from the T7 promoter a computerized image analysis system. Images were ac-
by in vitro transcription of 1 mg of plasmid template with quired through a 3-CCD video camera attached to a Ni-
50 units of T7 RNA polymerase in the presence of 50 kon-FXA microscope. The digitized images were ana-
mCi of 35S-UTP and 35S-ATP. Two labeled nucleotides lyzed with the Optilab software version 2.1 (Graftek, Mir-
were included in the transcription reaction so as to in- mande). To count the number of silver grains in GC, LN
crease the specific activity of the probe. After incubation sections were viewed at a final magnification of 1000. A
for 1 hr at 377, the DNA template was digested with 10 threshold was set so as to distinguish the silver grains
units DNase I for 15 min at 377. To enhance the penetra- from the lymphoid tissues. The number of silver grains
tion of the probe into tissue sections, the 35S-labeled was automatically counted on a 1000-mm2 region, and
RNA was subjected to mild alkaline hydrolysis in 80 mM the evaluated background for each section was sub-
NaHCO3 and 120 mM Na2CO3 at 607. The hydrolysis time tracted. The mean count attained for 3 to 5 measure-
was optimized to obtain a majority of fragments in the ments in distinct GC defined the density of silver grains,
150- to 200-nucleotide range. After neutralization with reported in Fig. 3C. Productively infected cells in LN were
600 mM Na acetate and 167 mM acetic acid, the probe counted manually on a 2-mm2 grid. The mean count ob-
was purified by phenol chloroform extractions and etha- tained for three sections is indicated in Fig. 3A. The inten-
nol precipitation. Specific activity ranged between 1 1 sity of productive infection was quantified in individual
108 and 2 1 108 dpm/mg of input DNA. cells, by automatically counting the number of silver
grains per hybridization spot. The mean count obtained
In situ hybridization
for 10 measurements is reported in Fig. 3B.
The development of GC was evaluated by morphome-Hybridization techniques were based upon published
procedures (Singer et al., 1987). Hybridization was car- try, using the same image analyzing system as above.
To quantify the percentage of the LN surface occupiedried out in tissue sections freshly cut on the cryostat, to
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by GC, tissue sections were viewed at a final magnifica- 0.02% with SIV 251 Dnef (Fig. 1B). This 2 to 3 log10 differ-
ence indicated that attenuated SIV induced a particularlytion of 50. The surface of each GC was measured, and
the sum was divided by the surface of the entire LN low viral burden in the blood. The number of PBMC ex-
pressing viral RNA in the 239 nef stop infection wassection (Fig. 5A). When GC were too numerous to be
individually measured, the mean surface obtained for 10 intermediate, with peak values 1 to 2 log10 lower than
those seen in the infection with the 251 isolate. AdditionalGC times the total number of GC was used in the compu-
tation. experiments based on a coculture assay with CemX174
cells (Moog et al., 1994) were performed to evaluate the
low viral burden found in attenuated infections. The num-RESULTS
ber of infected PBMC in coculture was found to be in
Design of the study the same range as that obtained by in situ hybridization,
with peak values of 0.02% in the 251 Dnef infection andThe objective of this work was to compare the primary
of 0.1% in the 239 nef stop infection (data not shown).infections caused by attenuated and pathogenic SIV in
The virus derived in vivo from the SIVmac 239 nef stopLN. For attenuated virus, we used a SIVmac 251 Dnef
clone was genetically characterized to determine themolecular clone which has a 174-bp deletion in the nef
point at which the premature nef stop codon might havegene and an additional mutation of the nef initiation co-
reverted. For each of the three animals infected with SIVdon (Kieny et al., 1993). The second clone used, SIVmac
239 nef stop, DNA was extracted from lymph node cells239 nef stop, is similar to the fully pathogenic SIVmac
obtained at early time points. A 166-bp fragment of the239 clone except that it carries an in-frame stop codon
SIV nef gene encompassing the stop codon was ampli-in nef at nucleotide 9353 (Regier and Desrosiers, 1990).
fied by nested PCR, cloned, and sequenced. The rever-Inoculation of Rhesus macaques with the SIVmac 239
sion of the stop codon was found to occur early, duringnef stop clone was shown to induce a pathogenic infec-
the second week postinoculation (Table 1). The stop co-tion, due to the rapid reversion of the in-frame stop codon
don was still present in all PCR clones at Day 7, but only(Kestler et al., 1991). We reasoned, however, that this
in 40% of the clones at Day 15, and it was reverted in allclone would display an attenuated phenotype prior to
cases at Day 30. As the peak of productive infection wasthe reversion and that it could be used to evaluate the
observed between Days 7 and 15, it can be assumed thatconsequences of an initial attenuation on the subsequent
a significant portion of the viruses produced in primarycourse of a pathogenic infection.
infection harbored a functional nef gene and thus wereThree rhesus macaques were inoculated with SIV 251
potentially pathogenic. It should be noted, however, thatDnef, and three others with SIV 239 nef stop. For each
the viral burden in PBMC remained lower than that ob-animal, four axillary or inguinal LN were sequentially col-
served for a directly pathogenic virus.lected between 7 and 63 days p.i. SIV infection in LN
was analyzed by in situ hybridization, and histologic Course of attenuated SIV infection in LN
changes in LN were evaluated by morphometry. Blood
The kinetics of SIV dissemination in lymphoid organssamples were also regularly obtained and evaluated for
was determined by in situ hybridization. The course ofviral burden and T cell subsets. The results were com-
SIV 251 Dnef infection in LN is represented in Fig. 2.pared to those previously obtained in four animals inocu-
The initial stage was characterized by the presence oflated with the pathogenic SIVmac 251 isolate (Chakra-
numerous productively infected cells, visible as blackbarti et al., 1994a).
spots on the photographs. Subsequently, the rate of pro-
ductive infection decreased, while a more diffuse hybrid-Viral burden in the blood
ization signal accumulated in the developing GC. The
diffuse signal indicated the accumulation of viral parti-Measurement of antigenemia showed that the two SIV
clones induced a very low viral burden in the blood. cles trapped at the surface of follicular dendritic cells
(Chakrabarti et al., 1994b). The course of the Dnef infec-Using an antigen capture ELISA test (Coulter) with a limit
of detection of 50 pg/ml, the p27 antigen was undetect- tion in LN paralleled that observed in pathogenic SIV
infection, as the successive stages of productive infec-able in the serum of animals infected with SIV 251 Dnef
and with SIV 239 nef stop (Fig. 1A). In contrast, p27 tion and particle accumulation occurred at the same time
points. The viral burden was lower in the Dnef infectionwas detected at high levels in animals infected with the
pathogenic 251 isolate, with peak values of 200 to 3000 (see below). However, the number of LN cells productively
infected with SIVDnef was not negligible at Day 7, whenpg/ml.
Each virus induced a different cell-associated viremia. compared to the limited number of infected cells detected
in the blood. These data showed that attenuated SIV wasThe number of PBMC expressing viral RNA that was
detected by in situ hybridization reached 4% with the actively disseminated in LN during primary infection.
Individual variability was observed among animalspathogenic isolate, while it ranged between 0.003 and
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FIG. 1. Quantitation of the viral burden in blood. (A) The antigenemia was detected using an antigen capture ELISA specific for SIV Gag p27.
The dashed line indicates a cutoff value of 50 pg/ml. (B) The rate of PBMC infection was determined by in situ hybridization of PBMC spotted onto
slides with a SIV-specific riboprobe. Three slides of 105 PBMC were evaluated at each time point. The mean number of hybridization spots per 100
PBMC is reported.
inoculated with SIV 251Dnef, as shown by the different the cortical and paracortical areas (Fig. 3A). The mean
viral loads in LN of animals 90141 and 90154 (Fig. 2). number of productively infected cells detected per 2 mm2
The differences were visible as early as 7 days p.i., during the acute stage was 13 in the Dnef infection,
with a higher number of infected cells in 90154 LN. while it reached 150 in the pathogenic 251 infection. The
Differences were more marked immediately after pri- viral load caused by the attenuated virus was reduced
mary infection, as viral particles accumulated in 90154 by 1 to 1.5 log10 in LN, depending on the animal. These
LN, while they appeared to be cleared from 90141 LN. data contrasted with the 2 to 3 log10 difference observed
Thus, rhesus macaques showed variable individual in the rate of PBMC infection between the two viruses
susceptibilities to attenuated SIV, similar to the phe- (see above). This suggested that cells infected with the
nomenon documented with pathogenic SIV. Dnef virus preferentially localized in the lymphoid organs
or that they were more efficiently cleared from the blood-
Quantitation of productive infection in LN stream. Intermediate levels of infection were observed
in LN of animals infected with SIV 239 nef stop. At DayThe productive infection in LN was quantified by count-
ing the number of hybridization spots per surface unit in 7, while most of the viruses still contained a defective
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TABLE 1
Reversion of the SIV 239 nef Stop Mutation in Vivo
Note. The amino acid (aa) sequence of clones obtained by PCR amplification of LN DNA is presented. SIV 239-specific primers surrounding the
nef stop mutation (nucleotide 9353) were used to amplify DNA from Days 7, 15, and 30 LN in the three animals studied. The aa identical to those
of the original 239 nef stop clone (top line) are indicated by dashes. The arrow indicates the position of the original in-frame stop codon in nef.
nef gene, the mean number of infected cells was 32 Attenuation was characterized by a reduced number
of target cells, but not by a reduced production of virusper 2 mm2, which represents about five times less virus
per target cell.than in the pathogenic 251 infection. As the difference
was 1 to 2 log10 in the blood, it could be concluded
that SIV 239 nef stop infection was also characterized
by a preferential localization of infected cells in Quantitation of viral particles trapped in LN
lymphoid tissues.
To estimate the intensity of SIV replication in its target The second component of the viral burden, consisting of
cells, we quantified the amount of viral RNA detected per viral particles trapped in GC, was also quantified (Fig. 3C).
productively infected cell. The mean number of silver The diffuse hybridization signal was measured by automati-
grains per hybridization spot was automatically counted cally counting the number of silver grains per surface unit
on LN sections obtained at Day 7, using a computerized in the GC area. The measurement was done in areas de-
image analyzing system (Fig. 3B). Slides were exposed void of hybridization spots, so that only the diffuse signal
for only 2 days in this experiment, to avoid saturation at associated with the FDC network was taken into account.
high grain counts. The production of SIV RNA per cell The density of viral RNA showed a peak between Days 15
was found to be equivalent in the three types of infec- and 30 and thus appeared to follow in time the peak of
tions, with a count ranging from 150 to 300 grains/cell. productive infection. However, the levels of viral RNA de-
Taken together, these results showed that attenuated posited in the GC were not directly proportional to the peak
SIV maintained the ability to replicate productively in of productive infection. Some animals infected with the 251
vivo and that the intensity of viral gene expression Dnef and 239 nef stop viruses showed a marked accumula-
tion of viral RNA, though they had a limited number ofcould be as high as that observed for pathogenic SIV.
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FIG. 3. Quantitation of the viral burden detected by in situ hybridization in LN. The two types of hybridization (spots and diffuse signal) detected
in LN of SIV-infected macaques were quantified. (A) The number of productively infected cells, detected as spots, was counted in a 2-mm2 area in
the paracortex. The mean number obtained for three sections is reported. (B) The intensity of SIV replication in its target cells was measured by
counting the number of silver grains per hybridization spot. This measurement was made by image analysis on Day 7 LN, using tissue sections
exposed for only 2 days to avoid saturation. The mean and standard deviation obtained for 10 measurements are indicated. (C) The diffuse
hybridization signal in GC was quantified by image analysis. The density of silver grains per 1000 mm2 represents the mean of three to five
measurements made in distinct GC. Bars indicate standard deviations.
productively infected cells during the acute stage. This was while the number of productively infected cells was 1 log10
lower. These observations suggested that the proportionapparent for animal 90154, infected with SIV 251Dnef. The
viral RNA levels detected in GC of 90154 LN were similar of viral particles that were trapped in LN could be high in
attenuated SIV infection.to those found in certain cases of pathogenic 251 infection,
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FIG. 4. Evolution of immunological parameters in the course of SIV infection. (A) Evolution of the T4/T8 lymphocyte ratio. Peripheral blood samples
were labeled with OKT4 (anti-CD4) and Leu2a (anti-CD8) monoclonal antibodies conjugated to phycoerythrine and fluoresceine and analyzed by
flow cytometry. The dashed line marks the level at which T4/T8  1. (B) Development of the antibody response against SIV. Macaque sera diluted
from 1:10 to 1:100,000 were tested with an HIV-2 antibody ELISA that cross-reacts with SIV.
Clinical progression One of the animals with a low ratio, PH426, developed
AIDS at 8 months p.i. and was sacrificed because ofImmunological parameters and clinical progression
intestinal necrosis. Two other animals of the group, P3
differed between the three types of infections. The T4/
and OH430, died in the third year of infection. None of
T8 ratio of circulating lymphocytes remained normal in
the animals infected with the Dnef or the nef stop virus
the 251 Dnef infections, while a ratio persistently below
exhibited clinical symptoms over a 1-year follow-up pe-
1 was observed in one of the macaques infected with
riod. In summary, SIV 251 Dnef infection was benign,
the 239 nef stop virus (Fig. 4A). This animal, 52169, expe-
SIV 239 nef stop caused a slowly progressive infection
rienced a slow decline in T4 lymphocytes, reaching a
in one animal, and SIV 251 caused a rapid disease in a
T4/T8 ratio of 0.7 at 6 months p.i. It should be noted that,
subset of the infected animals.
during primary infection, 52169 had shown a higher viral
burden in LN and PBMC than the other two macaques Early humoral response
of its group. Among the four macaques infected with
the pathogenic 251 isolate, two demonstrated a rapid We asked whether we could detect differences in the
early immune response associated with the three typesdecrease, with a T4/T8 ratio down to 0.4 at 6 months p.i.
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of infections. The development of the humoral response ported the notion that ongoing development of GC into
the asymptomatic phase of infection was indicative ofwas monitored on serum samples by an ELISA test (Fig.
4B). The anti-SIV antibodies became detectable at Day pathologic progression.
We next addressed the question of whether rapid GC6 for the Dnef infection, and between Days 6 and 20 in
the 239 nef stop and 251 infections. Acid dissociation of development in attenuated infection lead to an overall
increase of the trapping of SIV particles at early timeimmune complexes in serum did not significantly change
the O.D. curves (data not shown). It could be concluded points. Both the density of silver grains in GC and the
surface occupied by GC had to be taken into account.that the appearance of circulating antibodies was as
rapid in attenuated infections as in pathogenic ones. The density of grains was generally higher in pathogenic
infections (Fig. 3C), while the percentage of LN surfaceAt later time points, the pathogenic SIV 251 infection
induced higher antibody titers than the SIV 251 Dnef occupied by GC was larger in attenuated infections (Fig.
5A). To evaluate the global amount of viral particles re-infection, which probably reflected the higher viral bur-
den in the former case. The 239 nef stop infections also tained in LN, we multiplied both parameters (Fig. 5B).
The resulting number, which corresponded to a densitygave rise to high titers, suggesting a progression toward
a higher viral burden. of viral particles per surface unit of LN tissue, was pro-
portional to the total number of particles trapped in LN,
given that LN sizes were approximated to be equal. ThisDevelopment of germinal centers
approximation could be made for early time points, be-
fore the LN infected with the 251 isolate became hyper-In the course of a humoral response, affinity matura-
tion of antibodies takes place in GC that develop in plasic.
The quantity of viral particles retained in LN at Day 15lymphoid tissues (Liu et al., 1992). We investigated the
kinetics of GC development as a measure of the matura- was found to vary with the animal (Fig. 5B). The accumu-
lation of virus in LN could be much higher in certaintion of the anti-SIV humoral response. An initial observa-
tion was that numerous GC were visible in LN infected cases of attenuated infection than in pathogenic infec-
tion. The two animals for which the amount of virus re-with SIV 251 Dnef at Day 7 (Fig. 2), which was not the
case in the pathogenic 251 infection. To quantify this tained in LN was important, 90154 and 52169, were char-
acterized by a high rate of productive infection as com-phenomenon, the surface occupied by GC at each time
point was measured by image analysis, and the number pared to other animals of the 251 Dnef and 239 nef stop
groups. This suggested that, in attenuated SIV infection,obtained was divided by the surface of the whole LN
section. This measurement indicated that the develop- virus trapping could compensate for virus production. In
contrast, the four animals infected with the pathogenicment of GC was more rapid in attenuated SIV infection
(Fig. 5A). This was apparent from Day 7 to Day 15, when isolate had a limited amount of virus trapped in LN at
Day 14, though the number of cells producing virus wasGC occupied 1 to 2% of LN sections in the pathogenic
infection, and 3 to 8% in the Dnef infection. These differ- high at this stage. It should be noted that P4, which had
relatively more virus trapped in LN than the three otherences suggested a more efficient development of the
humoral response in attenuated SIV infection or, con- animals, had the lowest antigenemia in the group and
progressed more slowly to disease. Taken together,versely, an early impairment of the humoral response in
pathogenic SIV infection. these data suggested that the clearance of antigenemia
depended on the capacity of GC to trap circulating viralThe reaction of LN in the SIV 239 nef stop infection
was similar to that observed in the 251 Dnef infection, particles.
with GC development occurring during the first 2 weeks
postinoculation (Fig. 5A, middle panel). Thus, both anti- DISCUSSION
bodies and GC measurements indicated that SIV 239 nef
stop induced an immune response of the type seen in This study indicates that attenuated and pathogenic
SIVs induce different viral burdens, but also different im-attenuated infection. At later time points, the trend was
reversed, as the size of GC decreased in the Dnef and mune responses during primary infection. An initial ob-
servation was that, in terms of viral burden, the attenua-nef stop infections, while they kept increasing in the
pathogenic SIV 251 infection. These data could be inter- tion was more marked in the blood than in LN. In periph-
eral blood, SIV 251 Dnef infected 2 to 3 log10 fewer cellspreted as the normal resolution of an immune response
in the first two cases, and as a progression toward follicu- than the SIV 251 isolate, while in LN, the number of
infected cells was reduced by 1 to 1.5 log10 only. A possi-lar hyperplasia in the pathogenic 251 infection. The two
animals which showed the highest percentage of LN ble explanation was that SIV 251 Dnef preferentially in-
fected cells that homed or resided in LN, because thearea occupied by GC at 2 months (PH426 and OH430,
Fig. 5A, right panel) were those which showed a rapid activation status of these cells allowed the infection with
a virus defective for nef. Another explanation was thatdecline of the T4/T8 lymphocyte ratio (Fig. 4A). This sup-
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FIG. 5. Development of germinal centers during primary SIV infection. (A) The development of GC was measured by image analysis. The percentage
of LN tissue occupied by GC was obtained by measuring the surface of each GC and by dividing the sum by the surface of the entire LN section.
Arrows emphasize that, during the first 2 weeks, the development of GC is more advanced in SIV 251 Dnef and SIV 239 nef stop infections than
in SIV 251 infection. (B) Evaluation of the quantity of viral particles retained in LN at Day 14/15. The density of silver grains in GC was multiplied
by the percentage of LN tissue occupied by GC. The resulting parameter represents the quantity of viral particles trapped per surface unit of LN
tissue.
the immune response was more efficient in clearing the the total anti-SIV antibody production. Antibodies can be
sequestered in LN, as FDC are known to trap and retaininfecting virus or the infected cells from the bloodstream.
The observation that p27 antigenemia was undetectable antigen– antibody complexes for long periods on their
cell membrane (Liu et al., 1992), and as HIV particle–in the sera of animals infected with SIV 251 Dnef, while
an active viral replication took place in LN, supported antibody complexes are able to bind to the surface of
isolated FDC in a complement-dependent manner (Jolingthe idea that the antiviral immunity was efficient in clear-
ing the virus from the blood. et al., 1993). The trapping of immune complexes in devel-
oping GC is likely to delay the appearance of circulatingThe seric levels of anti-SIV antibodies were monitored
anti-SIV antibodies.to evaluate whether the humoral response could account
for p27 antigenemia clearance. There was no conclusive The examination of LN was needed to better evaluate
the development of the anti-SIV humoral response. Mor-evidence for a more rapid antibody response in attenu-
ated SIV infection. However, it should be considered that phometric measurements demonstrated that the develop-
ment of GC was more rapid in attenuated SIV infectionthe measure of seric antibody levels only partially reflects
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(Fig. 5A). Other investigators have shown that cells in- pathogenic SIV infection suggest the occurrence of a
transient immunosuppression, which could facilitate viralfected with the attenuated SIVmac 1A11 localize preferen-
tially in GC 2 weeks after inoculation, which confirms that dissemination. This strategy is probably common to other
lymphotropic viruses, such as measles and canine dis-expanded GC can be detected very early in LN infected
with attenuated SIV (Lackner et al., 1994). As GC develop- temper viruses, which are known to cause an episode
of immunosuppression associated with acute infectionment reflects the process of affinity maturation of antibod-
ies (Liu et al., 1992), our findings suggest that the synthesis (Rouse and Horohov, 1986). The chain of events leading
to a transient immunosuppression remains to be investi-of high-affinity antibodies that can efficiently complex viral
particles occurs earlier in attenuated SIV infection. In addi- gated. Pathogenic SIV or HIV, being initially more infec-
tious, may rapidly induce a viral burden sufficient to par-tion, the development of GC means a larger FDC network
into which viral particles can be trapped and thus removed tially destroy or disregulate T4 helper lymphocytes and
thus may inhibit the T4-dependent steps needed to initi-from the lymph and bloodstream. The evaluation of the
amount of virus trapped in LN at Day 15 confirmed that ate specific cellular and humoral responses. The fact
that T4 lymphopenia and reduced T cell proliferative re-this process was more efficient in attenuated infection
(Fig. 5B). The animals that showed an increased suscepti- sponses are frequent findings in primary HIV infection
(Cooper et al., 1988; Pedersen et al., 1990) supports thebility to SIV 251Dnef or SIV 239 nef stop, as indicated by
a higher rate of productive infection, also had a larger possibility of very early T4 cell dysfunction.
In conclusion, this study provides evidence that attenu-amount of virus trapped in LN. This could explain why
these animals maintained undetectable or very low anti- ated and pathogenic SIV differ not only in the viral bur-
den, but also in the immune response they elicit duringgenemia levels. In the pathogenic 251 infection, the num-
ber of GC appeared limiting, so that despite a higher primary infection. The initial conflict between immune
response development and viral dissemination appearsdensity of particles per GC, the total amount of virus
trapped in LN remained low at early time points. Circulat- crucial in determining the subsequent course of infec-
tion. This notion provides a rationale for attempting verying particles could enter further rounds of replication, lead-
ing to an increased viral burden. Thus, the rapidity of GC early antiviral therapies. A recent study indicates that
immediate AZT treatment alleviates the severity of pri-development appeared as a key determinant of the sever-
ity of primary SIV infection. mary SIV infection in macaque neonates and restores
antibody responses in these susceptible animals (VanThe study of the SIV 239 nef stop infection confirmed
the importance of early events in determining the clinical Rompay et al., 1995). The SIV model will be valuable
to test further approaches aimed at early therapeuticoutcome. Animals infected with SIV 239 nef stop showed
an intermediate viral burden and a slower progression intervention.
to disease than those infected with a pathogenic isolate.
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